Global Animal Livestock Drugs Market, By Type (Cattle, Sheep, Pigs, Goats, Horses, Others), Product (Drugs, Vaccines, Medicated Feed Additives), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, the animal livestock drugs market is anticipated to grow rapidly during the forecast period. The animal medicine market makes up the animal medicine market sales of veterinary medications and related services by entities (organizations, sole traders, and partnerships) that manufacture veterinary medicines used to cure animal ailments and/or improve animal performance and health. Establishments that manufacture veterinary pharmaceuticals such as veterinary vaccinations, veterinary antibiotics, and other veterinary pharmaceuticals and medical feed additives and nutritional feed additives make up the animal medicine sector. Veterinary pharmaceuticals, feed additives, and livestock and companion animal medicines are the most common types of animal medicines.
Data Bridge Market Research analyses that the animal livestock drugs market was valued at USD 33.939 billion in 2021 and is expected to reach USD 51.69 billion by 2029, registering a CAGR of 5.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Except for poultry, animal livestock refers to farmed ruminants and domestic animals. Cattle, goats, sheep, donkeys, pigs, horses, and other animals are the most common members of this class, but different animals may predominate in other areas' agriculture. The largest livestock group in the world is cattle (genus bos). Sheep of the genus ovis were among the first domesticated animals.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Cattle, Sheep, Pigs, Goats, Horses, Others), Drugs (Antibiotics, Vaccine, Others), End-Users (Veterinary Hospitals, Veterinary Specialty Clinics, Others), Distribution Channel (Veterinary Hospital Pharmacy, Retail Pharmacy, Veterinary Research Institute, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Mallinckrodt (US), Elanco (US), Boehringer Ingelheim International GmbH. (Germany), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Virbac (France), Vetoquinol (France), Zoetis (US), Ceva (France), Bimeda, Inc. (US), Dechra Pharmaceuticals PLC (UK)
|
|
Market Opportunities
|
|
Animal Livestock Drugs Market Dynamics
Drivers
- Increasing prevalence of zoonotic and food-borne diseases
The market is mostly driven by an increase in the global prevalence of zoonotic and food-borne diseases and a major increase in demand for protein diet. Companies are racing to develop new vaccinations and medications in response to this extraordinary spike in disease prevalence. Because of the increasing demand, there has been an increase in the number of companies making regular efforts to control pathogen contamination concerns and food-borne diseases, which is helping to drive market expansion.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of animal livestock drugs market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the animal livestock drugs market. Additionally, increasing penetration of pet insurance and surging demand for online veterinary pharmacies will expand the animal livestock drugs market.
Opportunities
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the animal livestock drugs market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.
Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the animal livestock drugs market growth during the forecast period.
Restraints/Challenges
On the other hand, the high cost associated with the animal drugs will obstruct the growth rate of the market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the animal livestock drugs market. Additionally, strict regulatory policies and lack of awareness among people will restrain and further impede the growth rate of the market during the forecast period of 2022-2029.
This animal livestock drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the animal livestock drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Animal livestock drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Animal Livestock Drugs Market
Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The animal livestock drugs market was hampered by the supply chain slowness. However, now that COVID-19 vaccines are readily available, numerous authorities are trying to assure that life-saving medications and vaccines are supplied without interruption. As a result, the market is projected to stabilize in the future.
Global Animal Livestock Drugs Market Scope
The animal livestock drugs market is segmented on the basis of type, product, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Cattle
- Sheep
- Pigs
- Goats
- Horses
- Others
Product
- Drugs
- Antiparasitic
- Anti-inflammatory
- Anti-infectives
- Vaccines
- Modified Live Vaccines [MLV]
- Killed Inactivated Vaccines
- Medicated Feed Additives
- Antibiotics
- Vitamins
- Amino Acids
- Enzymes
- Antioxidants
- Prebiotics and Probiotics
- Minerals
End-Users
- Veterinary Hospitals
- Veterinary Specialty Clinics
- Others
Distribution Channel
- Veterinary Hospital Pharmacy
- Retail Pharmacy
- Veterinary Research Institute
- Others
Animal Livestock Drugs Market Regional Analysis/Insights
The animal livestock drugs market is analysed and market size insights and trends are provided by country, type, product, end-users and distribution channel as referenced above.
The countries covered in the animal livestock drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the animal livestock drugs market because of the growing level of investment for research activities and rising healthcare expenditure in this region. Additionally, the presence of major key players will further propel the market's growth rate in this region.
Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to growing government awareness programs in this region. Also, development of healthcare infrastructure and surging number of generic drugs will further propel the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Animal Livestock Drugs Market Share Analysis
The animal livestock drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to animal livestock drugs market.
Some of the major players operating in the animal livestock drugs market are:
- Sanofi (France)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mallinckrodt (US)
- Elanco (US)
- Boehringer Ingelheim International GmbH. (Germany)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (US)
- Merck & Co., Inc. (US)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Virbac (France)
- Vetoquinol (France)
- Zoetis (US)
- Ceva (France)
- Bimeda, Inc. (US)
- Dechra Pharmaceuticals PLC (UK)
SKU-